Literature DB >> 3521692

Interaction between cyclosporin A and phenobarbitone.

H Carstensen, N Jacobsen, H Dieperink.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3521692      PMCID： PMC1401037          DOI： 10.1111/j.1365-2125.1986.tb02843.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  7 in total

Review 1.  Metabolism of cyclosporine.

Authors:  G Maurer
Journal:  Transplant Proc       Date:  1985-08       Impact factor: 1.066

2.  Rapid metabolism of cyclosporin and prednisone in kidney transplant patient receiving tuberculostatic treatment.

Authors:  E Langhoff; S Madsen
Journal:  Lancet       Date:  1983-10-29       Impact factor: 79.321

3.  Ketoconazole, cyclosporin metabolism, and renal transplantation.

Authors:  R M Ferguson; D E Sutherland; R L Simmons; J S Najarian
Journal:  Lancet       Date:  1982-10-16       Impact factor: 79.321

4.  Hepatic blood flow and drug metabolism in patients on enzyme-inducing anticonvulsants.

Authors:  H I Pirttiaho; E A Sotaniemi; R O Pelkonen; U Pitkänen
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

5.  Induction of propranolol metabolism by rifampicin.

Authors:  R J Herman; K Nakamura; G R Wilkinson; A J Wood
Journal:  Br J Clin Pharmacol       Date:  1983-11       Impact factor: 4.335

6.  Evaluation of cyclosporin-phenytoin interaction with observations on cyclosporin metabolites.

Authors:  D J Freeman; A Laupacis; P A Keown; C R Stiller; S G Carruthers
Journal:  Br J Clin Pharmacol       Date:  1984-12       Impact factor: 4.335

7.  Serum cyclosporin levels, hepatic drug metabolism and renal tubulotoxicity.

Authors:  C Cunningham; M P Gavin; P H Whiting; M D Burke; F Macintyre; A W Thomson; J G Simpson
Journal:  Biochem Pharmacol       Date:  1984-09-15       Impact factor: 5.858
  7 in total
  8 in total

Review 1.  Pharmacokinetic drug interactions with cyclosporin (Part II).

Authors:  G C Yee; T R McGuire
Journal:  Clin Pharmacokinet       Date:  1990-11       Impact factor: 6.447

Review 2.  Clinically significant drug interactions with cyclosporin. An update.

Authors:  C Campana; M B Regazzi; I Buggia; M Molinaro
Journal:  Clin Pharmacokinet       Date:  1996-02       Impact factor: 6.447

Review 3.  Treatment of concomitant illnesses in patients receiving anticonvulsants: drug interactions of clinical significance.

Authors:  P Loiseau
Journal:  Drug Saf       Date:  1998-12       Impact factor: 5.606

Review 4.  Primary care of the renal transplant patient.

Authors:  J D Pirsch; R Friedman
Journal:  J Gen Intern Med       Date:  1994-01       Impact factor: 5.128

5.  Cyclosporin-phenytoin interaction: re-evaluation using metabolite data.

Authors:  M Rowland; S K Gupta
Journal:  Br J Clin Pharmacol       Date:  1987-09       Impact factor: 4.335

Review 6.  Practical aspects in the use of cyclosporin in paediatric nephrology.

Authors:  P F Hoyer; J Brodehl; J H Ehrich; G Offner
Journal:  Pediatr Nephrol       Date:  1991-09       Impact factor: 3.714

Review 7.  Antiepileptic drugs. A review of clinically significant drug interactions.

Authors:  P N Patsalos; J S Duncan
Journal:  Drug Saf       Date:  1993-09       Impact factor: 5.606

Review 8.  Clinical pharmacokinetics in organ transplant patients.

Authors:  R Venkataramanan; K Habucky; G J Burckart; R J Ptachcinski
Journal:  Clin Pharmacokinet       Date:  1989-03       Impact factor: 6.447
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.